SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-134892
Filing Date
2020-12-14
Accepted
2020-12-11 19:57:31
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2038033-5_424b5.htm 424B5 662090
2 GRAPHIC lg_protagonist-4c.jpg GRAPHIC 35237
3 GRAPHIC tm2038033d2-org_pipline4clr.jpg GRAPHIC 138857
4 GRAPHIC tm2038033d1-org_pipline4clr.jpg GRAPHIC 140774
  Complete submission text file 0001104659-20-134892.txt   1097475
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-251254 | Film No.: 201384805
SIC: 2834 Pharmaceutical Preparations